B.Riley Financial Sticks to Its Buy Rating for Eton Pharmaceuticals (ETON)
B.Riley Financial analyst Madison Elsaadi reiterated a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today and set a price target ...
Outgoing Blue Cross CEO took pay cut as health insurer saw big operating loss
Michigan's largest health insurance company experienced its biggest underwriting loss last year in at least a decade.